| Literature DB >> 35795791 |
Sixian Li1, Xiaodong Cai1, Chen Yao1, Yuanqing Wang1, Xiaohua Xiao1, Huafeng Yang1, Yi Yao2, Lei Chen3.
Abstract
The onset of Lennox-Gastaut syndrome (LGS), a severe epilepsy syndrome, is typically before 8 years of age. Late-onset LGS (with onset in adolescence and adulthood) is relatively rare clinically and has some differences from classical LGS. Herein, we describe the case of a patient with late-onset LGS and provide a literature review of such cases. The patient had focal epilepsy onset at 8 years of age. After a 9-year evolution, he suffered seizures of different types and had a diagnosis of late-onset LGS. Drug treatment was ineffective. Nothing was found on stereotactic electroencephalography (SEEG) and magnetic resonance imaging (MRI) during the course of the disease. After the second presurgical evaluation, we found a suspicious focus on high-resolution structural MRI which was verified by SEEG at last. After SEEG-guided radiofrequency thermocoagulation (RFTC), his seizures were controlled, and his cognitive function and quality of living clearly improved. However, his seizures recurred 2 years later, and he underwent left occipital resection. Thereafter, his seizures have been controlled until now. This case emphasizes the importance of high-resolution structural MRI in the treatment of LGS. Furthermore, it suggests that late-onset LGS may be caused by focal lesions and evolve from focal epilepsy. Thus, characterizing the clinical symptoms and performing individualized electroencephalographic follow-up are both very important. Additionally, the clinical outcome in this case implies the value and limitations of RFTC in patients with epilepsy and a clear focal lesion. Moreover, this case further supports differences between late-onset and classical LGS in terms of clinical manifestation, cognitive changes, prognosis, and treatment.Entities:
Keywords: Case Report; late-onset Lennox-Gastaut syndrome; radiofrequency thermocoagulation; refractory epilepsy; stereotactic electroencephalography
Year: 2022 PMID: 35795791 PMCID: PMC9251299 DOI: 10.3389/fneur.2022.857767
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Figure 1(A) T2 fluid-attenuated inversion recovery (T2-FLAIR) magnetic resonance imaging showing a suspiciously unclear gray-white matter boundary around the left calcarine sulcus (white arrow). T1 magnetic resonance imaging showing a suspiciously unclear gray-white matter boundary around the left calcarine sulcus (black arrow). Positive emission tomography showing low metabolism at the cortex around the left calcarine sulcus (white arrow). (B) EEG background: generalized 2-2.5 Hz slow spike waves (SSWs) during wakefulness and generalized paroxysmal fast activity (GPFA) during sleep.
Figure 2EEG onset: epileptic spasm and tonic seizure involved general EEG onsets with little localization value.
Clinical characteristics, EEG and imaging findings, and other case details in 42 cases of late-onset Lennox-Gastaut Syndrome (LGS).
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 14 | 22 | T, AA, GTC | N | N | N | N | GPFA, SSWs | N | / | Y | N | / |
| 2 | M | 12 | 17 | T, AA, P | N | N | N | N | GPFA, SSWs, MS | N | / | Y | N | / |
| 3 | M | 17 | 46 | T, P | N | N | N | N | GPFA, SSWs, MS | N | / | Y | N | / |
| 4 | M | 6w | 8 | A, AA, T | AB | AB | VI | / | GPFA, SSWs, MS | / | Infection | Y | N | / |
| 5 | M | 18m | 8 | A, T | AB | AB | / | / | GPFA, SSWs, MS | / | / | Y | N | Mostly controlled |
| 6 | F | 9 | 19 | A, GTC | mild | AB | / | Slow | SSWs | / | / | Y | Y | Mostly controlled |
| 7 | F | 28 | 28 | AA, GTC | mild | AB | LH | Slow | SSWs | Right hemispheric stroke | Stroke | Y | Y | / |
| 8 | F | 7 | 32 | A, P, SI | AB | AB | / | Slow | SSWs | / | / | Y | Y | / |
| 9 | F | 13 | 27 | A, T, AA, GTC | N | N | N | N | GPFA, SSWs, GS | N | / | Y | N | / |
| 10 | F | 12 | 49 | T, AA, A, GTC | N | N | N | N | GPFA, SSWs, GS | N | / | Y | N | / |
| 11 | M | 17 | 61 | T, AA, M, GTC | N | N | N | N | GPFA, SSWs, GS | N | / | Y | N | / |
| 12 | F | 12 | 44 | T, AA, A, GTC | N | N | N | N | GPFA, SSWs, GS | N | / | Y | N | / |
| 13 | F | 16 | 41 | T, A, M, GTC | N | N | N | N | GPFA, SSWs, GS | N | / | Y | N | / |
| 14 | M | 11 | 40 | T, AA, A, GTC | N | N | N | N | GPFA, SSWs, GS | N | / | Y | N | / |
| 15 | F | 17 | 22 | T, AA, A, GTC | N | N | N | Slow | GPFA, SSWs, GS | N | / | Y | N | / |
| 16 | M | 13 | 26 | T, AA, A, GTC | N | N | N | Slow | GPFA, SSWs, GS | N | / | Y | N | / |
| 17 | / | 20 | 20 | T, AA, A, M, GTC | AB | / | / | / | GPFA, SSWs, MS | N | Brain injury | Y | N | / |
| 18 | F | 16 | 16 | T, A, GTC | N | / | N | / | GPFA, SSWs, GS | Low-lying cerebellar tonsils just below the foramen magnum level | / | Y | Y | Encephalopathy, DS |
| 19 | M | 5 | 32 | T, AA, A, GTC | N | / | N | / | GPFA, SSWs, GS | Small probable arachnoid cyst in the left frontal region | / | Y | Y | DS |
| 20 | F | 9 | 14 | T, AA, A, M, GTC | AB | / | N | / | GPFA, SSWs, GS | Modest ventricular dilatation | ALL with MTX | Y | N | Encephalopathy, DS |
| 21 | F | 15 | 26 | T, AA, A, M, GTC | N | / | N | / | GPFA, SSWs, GS | N | / | Y | Y | Encephalopathy, DS, SUDEP |
| 22 | M | 19 | 19 | T, A, GTC | AB | / | N | / | GPFA, SSWs, GS | N | Infection | Y | N | DS |
| 23 | F | 15 | 15 | T, AA, A, GTC | AB | / | N | / | GPFA, SSWs, GS | Single non-enhancing 6 mm focus in the paramedian inferior left cerebellum | / | Y | Y | VNS partially effective, DS |
| 24 | F | 11 | 11 | T, AA, A, GTC | N | / | N | / | GPFA, SSWs, GS | Gray matter of heterotopia with transmantle dysplasia | ALL with MTX; MCD | Y | Y | Encephalopathy, DS |
| 25 | F | 11 | 11 | T, AA, A, GTC | N | / | N | / | GPFA, SSWs, GS | Cerebellar atrophy | / | Y | Y | Encephalopathy, DS |
| 26 | F | 11 | 11 | T, A, GTC | AB | / | N | / | GPFA, SSWs, GS | Pachygyria, diffuse bilateral lissencephaly and band heterotopia | MCD | Y | Y | DS |
| 27 | F | 10 | 10 | T, AA, A, M, GTC | AB | / | N | / | GPFA, SSWs, GS | Mild cerebellar and cortical cerebral atrophy | / | Y | N | DS |
| 28 | F | 14 | 64 | AA, GTC, A | N | / | N | N | GPFA, SSWs, MS | N | / | Y | N | / |
| 29 | F | 9 | 27 | T, AA | AB | / | N | / | GPFA, SSWs | Moderate diffuse atrophy | trisomy 21 | Y | N | Weekly seizures, SUDEP |
| 30 | F | 8 | 12 | T, AA, A | AB | / | N | / | GPFA, SSWs | / | trisomy 21 | Y | N | DS |
| 31 | M | 11 | 14 | T, AA, A | AB | / | N | / | GPFA, SSWs | Multiple small subcortical calcification | trisomy 21 | Y | N | DS |
| 32 | F | 12 | 30 | T, AA | AB | / | N | / | GPFA, SSWs | N | trisomy 21 | Y | N | Seizures decreased |
| 33 | F | 8 | 33 | AA, A | AB | / | N | / | GPFA, SSWs | / | trisomy 21 | Y | N | Weekly seizures, SUDEP |
| 34 | M | 5 | 30 | T, GTC | AB | / | LH | / | GPFA, SSWs | / | trisomy 21 | Y | N | DS |
| 35 | M | 12 | 17 | T, AA | AB | / | N | / | GPFA, SSWs | Mild diffuse atrophy | trisomy 21 | Y | N | DS |
| 36 | M | 6 | 36 | T, AA, P, GTC | AB | / | N | / | GPFA, SSWs | / | trisomy 21 | Y | N | DS |
| 37 | M | 16 | 23 | T, AA, GTC | AB | / | N | / | GPFA, SSWs | Moderate diffuse atrophy | trisomy 21 | Y | N | DS |
| 38 | M | 11 | 12 | T, M, P | AB | / | N | / | GPFA, SSWs | Mild diffuse atrophy | trisomy 21 | Y | N | DS |
| 39 | M | 7 | 11 | T, AA, A, GTC | AB | / | N | / | GPFA, SSWs | N | trisomy 21 | Y | N | Weekly or monthly seizures |
| 40 | M | 10 | 43 | T | AB | / | N | / | GPFA, SSWs, MS | Dilation cortical sulci, calcification globus pallidus | trisomy 21 | Y | N | DS |
| 41 | M | 7 | 34 | T, AA | AB | / | N | / | GPFA, SSWs | Mild diffuse atrophy | trisomy 21 | Y | N | DS |
| 42 | M | 9 | 30 | T, AA, GTC | AB | / | slight cerebellar sign | Slow | GPFA, SSWs, MS | Asymmetrical cystic lesions in bilateral parietooccipital regions | Perinatal injury | / | / | / |
/, information not available; M, male; F, female; y, year; w, week; m, month; N, normal; AB, abnormal; A, atonic; AA, atypical absence; T, tonic; IS, infantile spasm; GTC, generalized tonic-clonic; P, partial; SI, startle induced; M, myoclonic; VI, visual impairment; LH, left hemiparesis; GPFA, generalized paroxysmal fast activity; SSWs, slow spike waves; MS, multifocal spikes; GS, generalized spike; ALL, acute lymphoblastic leukemia; MTX, methotrexate; MCD, malformations of cortical development; AEDs, antiepileptic drugs; VNS, vagal nerve stimulation; Y, yes, N, none; SUDEP, sudden unexpected death in epilepsy; DS, daily seizures.